Tuesday , September 29 2020

Gaming

AsclepiX Therapeutics Announces $ 35 Million Series A Funding

Proceeds to fund the development of AXT107 for the treatment of retinal diseases through phase 1 / 2a clinical studies Series A funding led by the Perceptive Xontogeny Venture Fund BALTIMORE – (BUSINESS WIRE) – June 24, 2020 – AsclepiX Therapeutics, Inc., a biopharmaceutical company that uses computer biology to …

Read More »